Navigation Links
Multi-Drug Therapy Effective in Lowering Blood Pressure

Researchers from the University of Florida College of Medicine designed a randomized //trial to compare two different treatments for hypertension in older patients.

Researchers say most patients require more than one medication to control their blood pressure, so this study was set up to look at multidrug strategies rather than individual drugs. The study found patients had similar outcomes when they took beta-blocker therapy or a calcium antagonist-based therapy.

The research included 22,576 hypertensive patients with coronary artery disease. The study was conducted over five years at 862 sites in 14 countries. The blood pressure goals were less than 140 millimeters of mercury (systolic) and less than 90 millimeters of mercury (diastolic). The goals for patients with diabetes or renal impairment were less than 130 millimeters of mercury (systolic) and less than 85 millimeters of mercury (diastolic). The patients were treated with a calcium antagonist strategy (CAS) or a non-calcium antagonist strategy (NCAS).

Researchers reported that after two years the blood pressure goals that were achieved were similar between the two groups. In the CAS patients, 65 percent of patients achieved the systolic goal compared with 64 percent of the patients in the NCAS group. Similarly, 88.5 percent of the CAS patients reached the diastolic goal and 88.1 of the NCAS patients reached the desired diastolic goal. There was also no significant difference in the number of deaths, heart attack or strokes that occurred in the two groups.

Researchers conclude this study supports the use of either strategy to lower blood pressure in patients with coronary artery disease. They also say the study shows that lower targets for blood pressure control can be achieved by using a multidrug strategy.


Page: 1

Related medicine news :

1. Multi-Drug Therapy Found To Be More Effective in Lowering B.P
2. Cancer Doctors Okays Controversial Prostate Therapy
3. Consensus on "Combination Therapy" for Breast Cancer
4. Gene Therapy shows promise in treating Hemophilia
5. "Make AIDS Therapy affordable" - Physicians demand
6. Hormone replacement Therapy a headache
7. Simple Therapy
8. Therapy for stopping the spread of cancer cells
9. Gene Therapy Destroys Pancreatic Cancer Cells
10. Letrozole Beats Tamoxifen in Breast Cancer Therapy
11. Garlic Supplements Impede HIV Therapy
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The ... and technical experience available within DataTrade to extend the services currently provided by ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate the ... 57 th American Society of Hematology (ASH) Annual ... myelomas as well as supportive care, including key findings ... personalized cell therapies. The ASH Annual Meeting will be ... . Novartis Oncology . "We will be ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, Ltd., ... and developing innovative therapies for ear, nose, and throat ... A. Katkin as chairman of the company,s board ... executive officer for OticPharma, Ltd.  "Keith brings a wealth ... will be able to share this experience and provide ...
Breaking Medicine Technology: